Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease.

Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease.

Show other versions (1)

Based on previous large-scale in silico screening several factor Xa inhibitors were proposed to potentially inhibit SARS-CoV-2 Mpro. In addition to their known anticoagulants activity this potential inhibition could have an additional therapeutic effect on patients with COVID-19 disease. In this stu...

Full description

Bibliographic Details
Main Authors:	Katarzyna Papaj, Patrycja Spychalska, Patryk Kapica, André Fischer, Jakub Nowak, Maria Bzówka, Manuel Sellner, Markus A Lill, Martin Smieško, Artur Góra
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0262482

Similar Items

Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
by: Katarzyna Papaj, et al.
Published: (2022-01-01)

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
by: Katarzyna Papaj, et al.
Published: (2021-11-01)

Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2
by: André Fischer, et al.
Published: (2021-02-01)

Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
by: André Fischer, et al.
Published: (2020-05-01)

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
by: Maria Bzówka, et al.
Published: (2020-04-01)

Transient binding sites at the surface of haloalkane dehalogenase LinB as locations for fine-tuning enzymatic activity
by: Agata Raczyńska, et al.
Published: (2023-01-01)

Transient binding sites at the surface of haloalkane dehalogenase LinB as locations for fine-tuning enzymatic activity.
by: Agata Raczyńska, et al.
Published: (2023-01-01)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022-06-01)

Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro
by: Zainab Jan, et al.
Published: (2023-01-01)

Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir
by: Karen Anbro Gammeltoft, et al.
Published: (2023-09-01)

In silico exploration of Lycoris alkaloids as potential inhibitors of SARS-CoV-2 main protease (Mpro)
by: Fredrick Mutie Musila, et al.
Published: (2022-09-01)

Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
by: János András Mótyán, et al.
Published: (2022-03-01)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
by: Rohan R. Narkhede, et al.
Published: (2020-06-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Natural phenolic compounds from Satureja L. as inhibitors of COVID-19 protease (Mpro): Computational investigations
by: Faika Başoğlu-Ünal, et al.
Published: (2022-01-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)
by: Pedro Henrique R. de A. Azevedo, et al.
Published: (2024-04-01)

PREDIKSI SENYAWA EUCALYPTUS SEBAGAI INHIBITOR POTENSIAL COVID-19 MAIN PROTEASE (Mpro) SECARA MOLECULAR DOCKING
by: Muhammad Fauzi, et al.
Published: (2021-05-01)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
by: N. Anis Ahamed, et al.
Published: (2023-12-01)

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
by: Ahmad Alzamami, et al.
Published: (2022-04-01)

Fluorogenic in vitro activity assay for the main protease Mpro from SARS-CoV-2 and its adaptation to the identification of inhibitors
by: Julien Ihssen, et al.
Published: (2021-09-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

A Computational Study to Identify Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) from Eucalyptus Active Compounds
by: Ibrahim Ahmad Muhammad, et al.
Published: (2020-09-01)

Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
by: Renhui Dai, et al.
Published: (2023-11-01)

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
by: Jonathan T. Lee, et al.
Published: (2022-08-01)

Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 Mpro
by: Zhengyuan Wang, et al.
Published: (2021-06-01)

Identification of Potential Natural Bioactive Compounds from Glycyrrhiza glabra as Sars-CoV-2 Main Protease (MPRO) Inhibitors: In-Silico Approach
by: Ashraf A. A. Abdusalam, et al.
Published: (2022-06-01)

Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations
by: Chirag N. Patel, et al.
Published: (2021-10-01)

Efficacy and Toxicity of Factor Xa Inhibitors
by: Maryna Bondarenko, et al.
Published: (2013-02-01)

Direct thrombin inhibitors and factor Xa inhibitors for atrial fibrillation
by: Mahtani, K, et al.
Published: (2017)

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 Mpro
by: A. Hussain, et al.
Published: (2022-04-01)

In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor
by: Doni Dermawan, et al.
Published: (2021-01-01)

Unlocking therapeutic potential: identifying small molecule inhibitors for SARSCOV-2 variants’ main protease (MPRO) through molecular docking analysis
by: Chong, Yie Woon, et al.
Published: (2024)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)
by: Felipe Moura A da Silva, et al.
Published: (2020-09-01)

Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations
by: Mithun Rudrapal, et al.
Published: (2022-04-01)

Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 Mpro inhibitors.
by: Malla, TR, et al.
Published: (2021)

Direct factor Xa inhibitor in the prevention of thromboembolism
by: Viktor Meretskyi, et al.
Published: (2019-01-01)

Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors
by: Persson PB
Published: (2015-05-01)